• Explore /
  • Poster
  • / A multicenter randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare).

A multicenter randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare).

Abstract Poster

Authors

null

Zhen Zhang

Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China

Zhen Zhang , Xinchen Sun , Anwen Liu , Yuan Zhu , Yaqun Zhu , Tao Zhang , Jianhui Jia , Shisheng Tan , Junxin Wu , Juying Zhou , Xin Wang , Jialin Yang , Yuanyuan Zhao , Hongyan Zhang , Chen Zhang , Gang Cai , Ji Zhu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Local-Regional Disease

Clinical Trial Registration Number

NCT02605265

Citation

J Clin Oncol 37, 2019 (suppl; abstr 3510)

DOI

10.1200/JCO.2019.37.15_suppl.3510

Abstract #

3510

Poster Bd #

2

Abstract Disclosures

Similar Posters

First Author: Ji Zhu

First Author: Ji Zhu

Poster

2021 Gastrointestinal Cancers Symposium

Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer: A single center phase II trial.

Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer: A single center phase II trial.

First Author: Wen Zhang

First Author: David Sebag-Montefiore